These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39077855)

  • 1. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy.
    Nogueiras-Álvarez R; Pérez Francisco I
    Br J Clin Pharmacol; 2024 Oct; 90(10):2483-2508. PubMed ID: 39077855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
    Saulsberry L; Olopade OI
    Cancer Cell; 2021 Jun; 39(6):730-733. PubMed ID: 34019805
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning of pharmacogenomics resources: moving towards precision oncology.
    Chiu YC; Chen HH; Gorthi A; Mostavi M; Zheng S; Huang Y; Chen Y
    Brief Bioinform; 2020 Dec; 21(6):2066-2083. PubMed ID: 31813953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?
    Hockings JK; Castrillon JA; Cheng F
    Hum Mol Genet; 2020 Oct; 29(R2):R177-R185. PubMed ID: 32601683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of pharmacogenomics in supportive oncology: a patient journey.
    Nguyen DG; Morris SA; Patel JN
    Pharmacogenomics; 2022 Oct; 23(15):807-811. PubMed ID: 36239145
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
    Lee JK; Liu Z; Sa JK; Shin S; Wang J; Bordyuh M; Cho HJ; Elliott O; Chu T; Choi SW; Rosenbloom DIS; Lee IH; Shin YJ; Kang HJ; Kim D; Kim SY; Sim MH; Kim J; Lee T; Seo YJ; Shin H; Lee M; Kim SH; Kwon YJ; Oh JW; Song M; Kim M; Kong DS; Choi JW; Seol HJ; Lee JI; Kim ST; Park JO; Kim KM; Song SY; Lee JW; Kim HC; Lee JE; Choi MG; Seo SW; Shim YM; Zo JI; Jeong BC; Yoon Y; Ryu GH; Kim NKD; Bae JS; Park WY; Lee J; Verhaak RGW; Iavarone A; Lee J; Rabadan R; Nam DH
    Nat Genet; 2018 Oct; 50(10):1399-1411. PubMed ID: 30262818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.
    O'Donnell PH; Ratain MJ
    Mol Oncol; 2012 Apr; 6(2):251-9. PubMed ID: 22321460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
    Mlakar V; Huezo-Diaz Curtis P; Satyanarayana Uppugunduri CR; Krajinovic M; Ansari M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil.
    Diasio RB; Johnson MR
    Pharmacology; 2000 Sep; 61(3):199-203. PubMed ID: 10971206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.
    Krens SD; McLeod HL; Hertz DL
    Pharmacogenomics; 2013 Apr; 14(5):555-74. PubMed ID: 23556452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
    Fatunde OA; Brown SA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?
    Kranzler HR; Smith RV; Schnoll R; Moustafa A; Greenstreet-Akman E
    Addiction; 2017 Dec; 112(12):2086-2094. PubMed ID: 28431457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine and economic evaluation in oncology: all theory and no practice?
    Garattini L; Curto A; Freemantle N
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):733-8. PubMed ID: 26289733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.